HUAZHONG PHARMACEUTICAL CO., LTD.
As of 18 November 2026, for the company name HUAZHONG PHARMACEUTICAL CO., LTD. as recorded, the chemical-drug catalogue lists 25 active records with this name as holder; 53 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
34 acceptance records as first applicant, grouped into 25 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Sitagliptin and Metformin Hydrochloride Extended-release Tablets 2 records · Latest accepted 2025/12/26
Generic · 2
Doxycycline Hyclate Tablets 1 records · Latest accepted 2025/11/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503937 | Generic | 2025/11/13 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Ticagrelor Tablets 1 records · Latest accepted 2025/10/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503761 | Generic | 2025/10/22 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Piracetam Injection 2 records · Latest accepted 2025/08/06
Generic · 2
维生素B6注射液 · No verified English name 1 records · Latest accepted 2025/03/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550157 | Supplement | 2025/03/25 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Aspirin Enteric-coated Tablets 1 records · Latest accepted 2025/01/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500315 | Generic | 2025/01/16 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Lincomycin Injection 1 records · Latest accepted 2024/12/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450625 | Supplement | 2024/12/25 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Dexamethasone Sodium Phosphate Injection 2 records · Latest accepted 2024/11/28
Supplement · 2
Sacubitril Valsartan Sodium Tablets 3 records · Latest accepted 2024/11/28
Generic · 3
Paracetamol Tablets 1 records · Latest accepted 2024/11/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401772 | Supplement | 2024/11/01 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Ibuprofen Injection 2 records · Latest accepted 2024/10/29
Generic · 2
Amikacin Sulfate injection 1 records · Latest accepted 2024/10/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450524 | Supplement | 2024/10/15 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Levonorgestrel Tablets 1 records · Latest accepted 2024/08/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450414 | Supplement | 2024/08/02 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Pimavanserin Tartrate Capsules 1 records · Latest accepted 2024/02/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2400037 | Generic | 2024/02/08 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Pentoxifylline Injection 1 records · Latest accepted 2023/09/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302437 | Generic | 2023/09/11 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Captopril Tablets 1 records · Latest accepted 2023/07/08
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301524 | Supplement | 2023/07/08 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Rocuronium Bromide Injection 2 records · Latest accepted 2023/06/22
Generic · 2
Piracetam Tablets 1 records · Latest accepted 2023/02/08
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300222 | Supplement | 2023/02/08 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
JQL胶囊 · No verified English name 1 records · Latest accepted 2023/01/06
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300013 | New drug | 2023/01/06 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Levocarnitine Injection 2 records · Latest accepted 2022/09/29
Generic · 2
Estazolam Tablets 1 records · Latest accepted 2022/06/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201032 | Supplement | 2022/06/23 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Diazepam Tablets 1 records · Latest accepted 2022/03/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250164 | Supplement | 2022/03/16 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Benproperlne Ptiospliate Tablets 1 records · Latest accepted 2021/12/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2151107 | Supplement | 2021/12/22 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Ibuprofen Tablets 2 records · Latest accepted 2021/09/16
Supplement · 2
Metronidazole Tablets 1 records · Latest accepted 2021/09/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150846 | Supplement | 2021/09/01 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Changes in the last 90 days
0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
Under review
9 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Sitagliptin and Metformin Hydrochloride Extended-release Tablets | CYHS2504418 | Generic | 2025/12/26 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Doxycycline Hyclate Tablets | CYHS2503937 | Generic | 2025/11/13 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Ticagrelor Tablets | CYHS2503761 | Generic | 2025/10/22 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Piracetam Injection | CYHS2502825 | Generic | 2025/08/06 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Piracetam Injection | CYHS2502824 | Generic | 2025/08/06 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Aspirin Enteric-coated Tablets | CYHS2500315 | Generic | 2025/01/16 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2404088 | Generic | 2024/11/28 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2404087 | Generic | 2024/11/28 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHS2404086 | Generic | 2024/11/28 | HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
Catalogue holder records
25 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Dexamethasone Sodium Phosphate Injection | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42021492 | 2026/03/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amikacin Sulfate injection | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42021497 | 2026/01/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pentoxifylline Injection | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H20254026 | 2025/04/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rocuronium Bromide Injection | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H20249723 | 2024/12/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rocuronium Bromide Injection | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H20249722 | 2024/12/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Captopril Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H20247254 | 2024/10/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levocarnitine Injection | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H20243926 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levocarnitine Injection | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H20243927 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Diazepam Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42021528 | 2023/07/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Benproperlne Ptiospliate Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42020604 | 2023/07/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ibuprofen Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42020606 | 2023/01/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ibuprofen Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42021408 | 2023/01/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metronidazole Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42020388 | 2022/12/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rifampicin Capsules | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42020401 | 2022/08/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Clindamycin Hydrochloride Capsules | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42021471 | 2021/10/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 诺氟沙星胶囊 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42020398 | 2021/07/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Estazolam Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42021522 | 2021/07/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Compound Sulfamethoxazole Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42022487 | 2021/07/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piracetam Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42020389 | 2021/01/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Chlorphenamine Maleate Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42020608 | 2020/12/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Propranolol Hydrochloride Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42022488 | 2020/10/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefalexin Capsules | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42020390 | 2020/09/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Captopril Tablets | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42020384 | 2020/07/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lincomycin Injection | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H42021515 | 2026/07/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 维生素B6注射液 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | HUAZHONG PHARMACEUTICAL CO., LTD. | 国药准字H20269248 | 2026/10/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
53 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 蛋白琥珀酸铁 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20250000596 | I | 2025/06/20 | CDE ↗ |
| 替格瑞洛 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20240001125 | A | 2026/03/12 | CDE ↗ |
| 沙库巴曲缬沙坦钠 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20230001132 | A | 2025/08/29 | CDE ↗ |
| 酒石酸匹莫范色林 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20230001160 | I | 2023/12/15 | CDE ↗ |
| 对乙酰氨基酚 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190008059 | A | 2025/11/01 | CDE ↗ |
| 烟酸 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190007881 | A | 2025/06/11 | CDE ↗ |
| 黄体酮 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190007880 | A | 2025/06/11 | CDE ↗ |
| 盐酸克林霉素 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190007879 | A | 2025/06/11 | CDE ↗ |
| 异烟肼 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190005004 | A | 2025/08/30 | CDE ↗ |
| 碘化钾 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190005003 | A | 2025/11/01 | CDE ↗ |
| 制霉素 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190005002 | A | 2025/11/01 | CDE ↗ |
| 乙酰谷酰胺 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190005001 | A | 2025/11/01 | CDE ↗ |
| 卡托普利 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190005000 | A | 2025/11/01 | CDE ↗ |
| 盐酸小檗碱 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004999 | A | 2025/11/01 | CDE ↗ |
| 苯丙酸诺龙 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004998 | A | 2025/11/01 | CDE ↗ |
| 丙酸睾酮 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004997 | A | 2025/11/01 | CDE ↗ |
| 甲氧苄啶 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004996 | A | 2025/11/01 | CDE ↗ |
| 甲睾酮 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004995 | A | 2025/11/01 | CDE ↗ |
| 炔诺酮 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004993 | A | 2025/11/01 | CDE ↗ |
| 醋酸曲安萘德 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004990 | A | 2025/11/01 | CDE ↗ |
| 戊酸雌二醇 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004989 | A | 2025/11/01 | CDE ↗ |
| 硝酸硫胺 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004843 | A | 2025/08/27 | CDE ↗ |
| 维生素B1 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004842 | A | 2025/08/27 | CDE ↗ |
| 芬布芬 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004835 | A | 2025/08/30 | CDE ↗ |
| 己酸羟孕酮 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004834 | A | 2025/08/30 | CDE ↗ |
| 劳拉西泮 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004833 | A | 2025/08/30 | CDE ↗ |
| 甘露六烟酯 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190004826 | A | 2025/08/30 | CDE ↗ |
| 双炔失碳酯 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003129 | A | 2025/06/11 | CDE ↗ |
| 地西泮 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003128 | A | 2025/06/11 | CDE ↗ |
| 吡拉西坦 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003125 | A | 2025/06/11 | CDE ↗ |
| 阿苯达唑 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003124 | A | 2025/06/11 | CDE ↗ |
| 氢化可的松 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003123 | A | 2025/11/28 | CDE ↗ |
| 左炔诺孕酮 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003122 | A | 2025/06/11 | CDE ↗ |
| 萘普生 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003121 | A | 2025/06/11 | CDE ↗ |
| 盐酸林可霉素 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003120 | A | 2025/06/11 | CDE ↗ |
| 泼尼松 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003119 | A | 2025/11/28 | CDE ↗ |
| 司坦唑醇 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003118 | A | 2025/11/28 | CDE ↗ |
| 醋酸可的松 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003117 | A | 2025/11/28 | CDE ↗ |
| 硝西泮 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003115 | A | 2025/11/28 | CDE ↗ |
| 泼尼松龙 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003114 | A | 2025/11/28 | CDE ↗ |
| 布洛芬 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003113 | A | 2025/06/11 | CDE ↗ |
| 醋酸泼尼松龙 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003111 | A | 2025/11/28 | CDE ↗ |
| 碘酸钾 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003110 | A | 2025/06/11 | CDE ↗ |
| 非那西丁 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003109 | A | 2025/06/11 | CDE ↗ |
| 醋酸泼尼松 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003108 | A | 2025/11/28 | CDE ↗ |
| 烟酰胺 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003104 | A | 2025/06/11 | CDE ↗ |
| 肌醇烟酸酯 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003102 | A | 2025/06/11 | CDE ↗ |
| 醋酸氢化可的松 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003092 | A | 2025/11/28 | CDE ↗ |
| 氯氮卓 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003091 | A | 2025/06/11 | CDE ↗ |
| 艾司唑仑 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190003090 | A | 2025/06/11 | CDE ↗ |
| 维生素B6 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20190000470 | A | 2026/03/27 | CDE ↗ |
| 盐酸普萘洛尔 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20170001428 | A | 2024/10/18 | CDE ↗ |
| 盐酸氯氮䓬 · No verified English name | HUAZHONG PHARMACEUTICAL CO., LTD. | Y20170001427 | A | 2024/10/12 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
1 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Furosemide Tablets | CYHS2300631 | Generic | 2023/02/24 | Hui Yu Yuan He (Hainan) Pharma Co., Ltd. romanized; HUAZHONG PHARMACEUTICAL CO., LTD. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.